Clinical TrialsSearch results
Number of results: 213
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Neoadjuvant chemotherapy using the TXL and CDDP followed by surgery for advanced gastric cancer - Phase II
- advanced gastric cancer
- TC therapy for gastric cancer study group
- 2005-11-09
Completed
- Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease
- Pneumococcal infection prevention
- Tanaka Yoshiyuki
- 2023-03-03
Recruiting
- Open label, long-term study evaluating safety and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2023-03-20
Recruiting
- Efficacy and safety of subcutaneous dupilumab for the treatment of adult participants with chronic pruritus of unknown origin (CPUO)
- Pruritus
- Tanaka Tomoyuki
- 2022-05-19
Recruiting
- A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab monotherapy compared with treatment withdrawal in participants aged 12 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-06-28
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 12 years and older with moderate-to-severe AD who have had an inadequate response to prior biologic therapy or an oral JAK inhibitor
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-05-08
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in participants aged 18 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13